Evidence that phospholipase D activation prevents group I mGluR-induced persistent prolongation of epileptiform

Marjorie J Rico1, Lisa R Merlin

  • 1Neural and Behavioral Science Program, School of Graduate Studies, State University of New York Downstate Medical Center, Brooklyn, New York 11203, USA.

Journal of Neurophysiology
|December 26, 2003
PubMed

Insights

L-cysteine sulfinic acid (CSA) prevents the development of prolonged seizure-like activity by acting on specific glutamate receptors. This amino acid blocks the induction phase, not the expression, suggesting a role in preventing protein synthesis essential for epileptogenesis.

Area of Science:

  • Neuroscience
  • Neuropharmacology
  • Epilepsy Research

Background:

  • Group I metabotropic glutamate receptors (mGluRs) play a role in epileptiform activity.
  • Selective activation of group I mGluRs can induce persistent, seizure-length discharges.

Purpose of the Study:

  • To investigate the effect of L-cysteine sulfinic acid (CSA) on group I mGluR-mediated epileptiform burst prolongation.
  • To determine the mechanism of CSA's action in preventing epileptogenesis.

Main Methods:

  • Using guinea pig hippocampal slices.
  • Inducing interictal bursts with picrotoxin and selectively activating group I mGluRs with (S)-3,5-dihydroxyphenylglycine (DHPG).
  • Testing the effects of CSA and a phospholipase D (PLD)-coupled mGluR antagonist (PCCG-13) on burst prolongation.

Main Results:

  • CSA prevented the induction of DHPG-induced burst prolongation but did not affect baseline activity or fully induced bursts.
  • CSA's effect was blocked when co-administered with PCCG-13, indicating agonist action at PLD-coupled mGluRs.
  • These findings suggest CSA acts during the induction phase, similar to protein synthesis inhibitors.

Conclusions:

  • CSA exhibits an antiepileptogenic effect by preventing the induction of persistent seizure-length discharges.
  • CSA likely acts as an agonist at PLD-coupled group I mGluRs.
  • CSA may prevent epileptogenesis by inhibiting the synthesis of a critical protein involved in group I mGluR-mediated mechanisms.